GET THE APP

 

The Role of CHA2DS2-VASc Score vs. Anticoagulation for Predicting Morbidity and Mortality for Ischemic Bowel Disease secondary to Atrial Fibrillation

Abstract

Neethi Dasu

Atrial fibrillation is a common disorder which can potentially have multiple adverse outcomes.  One such outcome is the development of ischemic bowel disease.  The aims of this study are: to  evaluate the role of CHA2DS2-VASc score as a predictor of higher mortality in patients who have atrial fibrillation and ischemic bowel disease, i.e. if a higher CHA2DS2-VASc score is associated with higher mortality; to evaluate whether being on anticoagulation is associated with a lower mortality for such patients in this population. 

PDF

Share this article